Comparative Pharmacology
Head-to-head clinical analysis: PARAFON FORTE DSC versus RALDESY.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PARAFON FORTE DSC versus RALDESY.
PARAFON FORTE DSC vs RALDESY
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorzoxazone acts on the central nervous system (CNS) at the spinal cord level, possibly by depressing polysynaptic reflexes, producing skeletal muscle relaxation without affecting neuromuscular transmission.
Selective beta-3 adrenergic receptor agonist; relaxes detrusor smooth muscle during storage phase of urinary bladder fill cycle, increasing bladder capacity and reducing urgency.
Adults: 4 g (500 mg x 8 tablets) orally every 6-8 hours as needed; maximum 8 g (16 tablets) per 24 hours.
Intravenous: 1 mg/kg every 8 hours; maximum single dose 100 mg.
None Documented
None Documented
1-3 hours (terminal); clinically relevant for dosing intervals of 4-6 hours.
4-6 hours in adults; prolonged to 8-12 hours in elderly or renal impairment (CrCl <30 mL/min)
Primarily renal (85-95% as glucuronide conjugates and unchanged drug; <5% fecal).
Primarily renal (85-90%) with 60% unchanged; biliary/fecal (10-15%)
Category C
Category C
Muscle Relaxant/Analgesic Combination
Muscle Relaxant